J. Klein

J. Klein, Jeffrey S. Miller, S. Spellman, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

J. Klein, P. Parham, M. Horowitz, 2007, Blood.

HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation.

J. Klein, C. Orosz, E. Copelan, 1994, Bone marrow transplantation.

Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen

J. Klein, E. Copelan, Tutschka Pj, 1987 .

Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen.

J. Klein, E. Copelan, P. Tutschka, 1987, Blood.

Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission.

J. Klein, A. Rimm, M. Horowitz, 1995, Bone marrow transplantation.

Survival of patients with chronic-phase chronic myeloid leukaemia on imatinib after failure on interferon alfa

J. Klein, D. Marin, J. Goldman, 2003, The Lancet.

Bone marrow transplantation for Fanconi anemia.

J. Klein, W. Friedrich, M. Horowitz, 1995, Blood.

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia

J. Klein, A. Barrett, M. Horowitz, 1998, Bone Marrow Transplantation.

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

John P Klein, Daniel J Weisdorf, J. Klein, 2002, Blood.

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.

J. V. Stone, J. Klein, J. Wingard, 1999, The New England journal of medicine.

study International Bone Marrow Transplant Registry (IBMTR) prospective Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and systems: a joint Société Française de Greffe de Moëlle et Thérapie Prospective evaluation of 2 acute graft-versus-host (GVHD) grading

J. Klein, D. Blaise, M. Horowitz, 2013 .

Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study.

J. Klein, D. Blaise, M. Horowitz, 2005, Blood.

Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial.

J. Klein, J. Passweg, E. Cohen, 2008, International journal of radiation oncology, biology, physics.

Analyzing center specific outcomes in hematopoietic cell transplantation

J. Klein, B. Logan, G. Nelson, 2008, Lifetime data analysis.

Methods for assessment of graft-versus-host disease [5] (multiple letters)

J. Klein, H. Deeg, R. Storb, 1998 .

High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Ovarian Cancer: An Autologous Blood and Marrow Transplant Registry Report

J. Klein, T. Shea, J. Veum-Stone, 2000, Annals of Internal Medicine.

The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase.

J. Klein, M. Horowitz, C. Anasetti, 2001, Blood.

Chemotherapy versus transplants for acute myelogenous leukemia in second remission.

J. Klein, M. Oken, R. Gray, 1996, Leukemia.

Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee.

E. Thiel, J. Klein, M. Horowitz, 1995, Annals of internal medicine.

Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy

J. Klein, M. Baccarani, M. Horowitz, 1997, British journal of haematology.

Recent developments in statistics and their applications

J. Klein, Jae Chang Lee, 1989 .

Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.

J. Klein, M. Horowitz, Stephanie J. Lee, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure.

J. Klein, S. Spellman, C. Anasetti, 2007, Blood.

Refinements of the Semiparametric Proportional Hazards Model

J. Klein, M. Moeschberger, J. Klein, 1997 .

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.

J. Klein, M. Horowitz, P. Cano, 2013, Blood.

Some stochastic models op cancer metastases

J. Klein, R. Bartoszynski, B. Jones, 1985 .

HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.

A. Nademanee, J. Klein, M. Horowitz, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program.

J. Klein, M. Horowitz, B. Logan, 2009, Blood.

IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE

J. Klein, A. Gratwohl, M. Horowitz, 1997, British journal of haematology.

Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose.

J. Klein, M. Horowitz, B. Logan, 2009, Blood.

Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia

J. Klein, Stephanie J. Lee, S. Spellman, 2012, Haematologica.

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

J. Klein, P. Parham, Jeffrey S. Miller, 2007 .

Semiparametric Proportional Hazards Regression with Fixed Covariates

J. Klein, M. Moeschberger, J. Klein, 1997 .

Current status of allogeneic and autologous blood and marrow transplantation: Report from the IBMTR and ABMTR — North America

J. Armitage, J. Klein, M. Horowitz, 1996 .

Small sample moments of some estimators of the variance of the Kaplan−Meier and Nelson-Aalen estimators

J. Klein, J. P. Klein, J. Klein, 1991 .

HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission.

J. Klein, A. Gratwohl, M. Horowitz, 1996, Leukemia.

Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.

J. Klein, M. Horowitz, H. Prentice, 1996, Bone marrow transplantation.

Adoptively Transferred γδ T Cells Indirectly Regulate Murine Graft-Versus-Host Reactivity Following Donor Leukocyte Infusion Therapy in Mice1

J. Klein, W. Drobyski, S. Vodanovic-Jankovic, 2000, The Journal of Immunology.

Adoptively transferred gamma delta T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infusion therapy in mice.

J. Klein, W. Drobyski, S. Vodanovic-Jankovic, 2000, Journal of immunology.

Bayesian Transformation Models for Multivariate Survival Data

J. Ibrahim, Ming-Hui Chen, J. Klein, 2014, Scandinavian journal of statistics, theory and applications.

Nested Case-Control and Case-Cohort Studies

J. Ibrahim, J. Klein, H. V. Houwelingen, 2016 .

Results of Transplanting Bone Marrow from Genetically Identical Twins into Patients with Aplastic Anemia

J. Klein, R. Gale, P. Rowlings, 1997, Annals of Internal Medicine.

Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).

N. Schmitz, E. Montserrat, J. Klein, 2000, Blood.

Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.

N. Schmitz, J. Klein, A. Gratwohl, 2006, Blood.

Joint Modeling of Death Times and Counts Using a Random Effects Model

J. Klein, Hee-Chang Park, 2005 .

Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

J. V. Stone, J. Klein, J. Wingard, 1999 .

Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study

J. Klein, J. Wagner, J. Kurtzberg, 2007, The Lancet.

Autotransplantation versus HLA‐matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research

J. Klein, M. Horowitz, R. Gale, 2006, British journal of haematology.

T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.

J. Klein, A. Barrett, A. Gratwohl, 2000, Blood.

Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.

J. Klein, M. Horowitz, S. Spellman, 2011, The Lancet. Oncology.

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

J. Klein, J. Wagner, M. Horowitz, 2000, The New England journal of medicine.

Bone marrow transplantation for severe aplastic anemia: has outcome improved?

J. Klein, M. Horowitz, R. Gale, 1997, Blood.

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.

J. Klein, M. Horowitz, J. Passweg, 2007, Blood.

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

J. Klein, M. Tallman, A. Keating, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Methods for equivalence and noninferiority testing.

John P Klein, Brent R Logan, J. Klein, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation.

J. Klein, S. Takemoto, S. Spellman, 2007, Blood.

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

Chap T Le, Tao Wang, John P Klein, 2010, Blood.

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

J. Klein, M. Horowitz, J. Wingard, 2014, Clinical Cancer Research.

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

John P Klein, Daniel J Weisdorf, Peter Greenberg, 2004, Blood.

Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.

John P Klein, Daniel J Weisdorf, Ciril Rozman, 2002, Blood.

Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.

J. Klein, W. Wood, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.

J. Klein, R. Gale, J. Passweg, 2007, Blood.

J. Klein, K. Sullivan, R. Gale, 2007, British journal of haematology.

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Harriet Noreen, Marcelo Fernandez-Vina, John Klein, 2007, Blood.

Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.

J. Klein, M. Horowitz, J. Goldman, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

survival after unrelated transplantation for acute myelogenous leukemia Donor selection for natural killer cell receptor genes leads to superior

J. Klein, C. Le, P. Parham, 2010 .

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes.

J. Klein, J. Sierra, M. Horowitz, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia

J. Klein, P. Parham, Jeffrey S. Miller, 2014, The Journal of Immunology.

The extent of primary melanoma excision. A re-evaluation--how wide is wide?

J. Klein, K. Clausen, D. Aitken, 1983 .

Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.

J. V. Stone, J. Klein, S. Tomany, 2001, Blood.

J. Armitage, J. Fay, J. Klein, 1999, JAMA.

Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia.

J. Klein, P. Layde, M. Horowitz, 2005, Chest.

Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry.

J. Klein, J. Wagner, M. Horowitz, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.

J. Armitage, J. Klein, S. Piantadosi, 2001, Experimental hematology.

Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.

J P Klein, J J van Rood, F H Bach, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.

J. Armitage, J. Fay, J. Klein, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States.

J. Klein, M. Horowitz, Stephanie J. Lee, 2005, Blood.

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia.

J. Klein, M. Horowitz, R. Gale, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation

John P. Klein, Martin Maiers, T. Andrew Binkowski, 2011, Bone Marrow Transplantation.

Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alt

J. Klein, N. Flomenberg, D. Vesole, 2002, Blood.

Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.

J. Klein, M. Horowitz, F. Locatelli, 2014, Blood.

Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.

J. Klein, D. Friedman, K. Ballen, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Klein, J. Wagner, J. Kurtzberg, 2005 .

T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.

J. Klein, C. Kabler-Babbitt, M. Hessner, 1999, Blood.

Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes.

J. Klein, J. Kurtzberg, J. Wingard, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

controlled study of conditioning regimens Bone marrow transplantation for severe aplastic anemia: a randomized

J. Klein, M. Horowitz, J. Passweg, 2013 .

J. Klein, M. Eapen, E. Perez-Albuerne, 2008, British Journal of Haematology.

Detection of BCR/ABL RNA transcripts using the polymerase chain reaction is highly predictive for relapse in patients transplanted with unrelated marrow grafts for chronic myelogenous leukaemia

J. Klein, M. Hessner, W. Drobyski, 1997, British journal of haematology.

Interleukin‐1 alpha genotype and outcome of unrelated donor haematopoietic stem cell transplantation for chronic myeloid leukaemia

J. Klein, M. MacMillan, S. Davies, 2007, British journal of haematology.

Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada.

J. Klein, M. Horowitz, Stephanie J. Lee, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation

J. Klein, Stephanie J. Lee, O. Ringdén, 2008 .

Comparison o f P reparative R egimens i n T ransplants f or Children W ith A cute L ymphoblastic L eukemia

J. Klein, M. Horowitz, R. Gale, 2000 .

Marrow Transplant Registry and the National Marrow Donor Program Wiskott-Aldrich syndrome: collaborative study of the International Bone Impact of donor type on outcome of bone marrow transplantation for

J. V. Stone, J. Klein, S. Tomany, 2012 .

Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation.

J. Klein, R. Blasczyk, Jun He, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry.

D. Berry, J. Klein, H. Parnes, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myelogenous Leukemia Unrelated Transplantation for Acute Mismatch Enhance the Clinical Benefit of Haplotypes, Recipient HLA-C1, and HLA-C Donor Killer Cell Ig-like Receptor B

Martha, Jeffrey, J. Klein, 2014 .

Erratum to "A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model" [Computer Methods and Programs in Biomedicine 88 (2007) 95-101]

Xu Zhang, Mei-Jie Zhang, John P. Klein, 2008, Comput. Methods Programs Biomed..

A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model

Xu Zhang, Mei-Jie Zhang, John P. Klein, 2007, Comput. Methods Programs Biomed..

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.

J. Armitage, P. Bierman, J. Vose, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests.

J P Klein, J. Klein, P. Andersen, 1999, Statistics in medicine.

Allogeneic bone marrow transplantation for low-grade lymphoma.

J. Armitage, J. Vose, J. Raemaekers, 1998, Blood.

Long‐term survival and late relapse in 2‐year survivors of autologous haematopoietic cell transplantation for Hodgkin and non‐Hodgkin lymphoma

J. Klein, H. Lazarus, N. Majhail, 2009, British journal of haematology.

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.

J. Armitage, J. Vose, J. Klein, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-Term Follow-up of Adults with Acute Lymphoblastic Leukemia in First Remission Treated with Chemotherapy or Bone Marrow Transplantation

E. Thiel, J. Klein, K. Sobocinski, 1995, Annals of Internal Medicine.

Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide–total body irradiation versus busulphan–cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission

J. Klein, R. Gale, M. Trigg, 2002, British journal of haematology.

Estimating the Survival Function in the Proportional Hazards Regression Model: A Study of the Small Sample Size Properties

John P. Klein, Per Kragh Andersen, J. Klein, 1996 .

Statistical Challenges in Comparing Chemotherapy and Bone Marrow Transplantation as a Treatment for Leukemia

Mei-Jie Zhang, John P. Klein, J. Klein, 1996 .

Multi‐state models and outcome prediction in bone marrow transplantation

J P Klein, N Keiding, N. Keiding, 2001, Statistics in medicine.

Autotransplants f or H odgkin's D isease i n P atients N ever Achieving R emission: A R eport F rom t he A utologous B lood and M arrow T ransplant R egistry

J. Armitage, P. Bierman, J. Vose, 2011 .

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.

S. Montoto, Sonali M. Smith, J. Klein, 2015, Biology of Blood and Marrow Transplantation.

Estimation of current leukaemia-free survival following donor lymphocyte infusion therapy for patients with leukaemia who relapse after allografting: application of a multistate model.

J P Klein, J. Klein, C. Craddock, 2000, Statistics in medicine.

Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission.

J P Klein, J. Klein, C. Craddock, 2000, Blood.

HIGH PROBABILITY OF LONG-TERM SURVIVAL IN 2-YEAR SURVIVORS OF AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA IN FIRST OR SECOND COMPLETE REMISSION

J. Klein, H. Lazarus, N. Majhail, 2010, Bone Marrow Transplantation.

Improved? Bone Marrow Transplantation for Severe Aplastic Anemia: Has Outcome

J. Klein, M. Horowitz, R. Gale, 2012 .

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

J. Klein, M. Horowitz, J. Wingard, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

hematopoietic stem cell transplantation in the United States Association of transplant center and physician factors on mortality after

J. Klein, M. Horowitz, Stephanie J. Lee, 2011 .

Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry.

J. Klein, M. Horowitz, R. Gale, 2000, Blood.

KIR Ligand Absence in Recipients of Unrelated Donor (URD) Allogeneic Hematopoietic Cell Transplantation (HCT) Is Associated with Less Relapse and Increased Graft Versus Host Disease (GVHD).

J. Klein, P. Parham, M. Horowitz, 2006 .

Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry--North America.

J. Armitage, J. Klein, M. Horowitz, 1994, Clinical transplants.

Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America.

J. Armitage, J. Klein, M. Horowitz, 1995, Clinical transplants.

Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants

John P Klein, Irwin Walker, J. Klein, 2004, British journal of haematology.

Effect of GVHD on the recovery of NK cell activity and LAK precursors following BMT.

J. Klein, E. Copelan, I. Cunningham, 1993, Bone marrow transplantation.

Allogeneic Hematopoietic Cell Transplantation Can Cure Some Patients with Acute Leukemia in Relapse or Primary Induction Failure: A CIBMTR Study.

J. Klein, J. Dipersio, M. Tallman, 2009 .

Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residence.

J. Klein, Stephanie J. Lee, H. Lazarus, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis.

J. Klein, R. Gale, L. Akard, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recipient survival and graft survival are not diminished by simultaneous liver‐kidney transplantation: An analysis of the united network for organ sharing database

J. Klein, K. Saeian, J. Bajaj, 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Matched Pairs Analysis of IV vs. PO Busulfan as a Conditioning Agent Prior to Transplantation.

P. Thall, J. Klein, M. Horowitz, 2004 .

SAS and R functions to compute pseudo-values for censored data regression

John P. Klein, Sergey S. Tarima, Per Kragh Andersen, 2008, Comput. Methods Programs Biomed..

9 Survival Analysis

John P. Klein, Mei-Jie Zhang, J. Klein, 2007 .

MODELING MULTISTATE SURVIVAL ILLUSTRATED IN BONE MARROW TRANSPLANTATION

J. Klein, C. Qian, 2007 .

Regression models for hazard rates versus cumulative incidence probabilities in hematopoietic cell transplantation data.

J. Klein, B. Logan, Mei-Jie Zhang, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Inference for Competing Risks

John P. Klein, Ruta Bajorunaite, J. Klein, 2003, Advances in Survival Analysis.

Survival Analysis, Software

John P. Klein, Mei-Jie Zhang, J. Klein, 2005 .

Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients.

J. Klein, Q. Xiang, H. Trivedi, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Bounds on net survival probabilities for dependent competing risks.

J P Klein, J. Klein, M. Moeschberger, 1988, Biometrics.

The Independence Assumption for a Series or Parallel System When Component Lifetimes Are Exponential

John P. Klein, M. L. Moeschberger, J. Klein, 1986, IEEE Transactions on Reliability.

Regression Analysis for Multistate Models Based on a Pseudo‐value Approach, with Applications to Bone Marrow Transplantation Studies

Per Kragh Andersen, J. Klein, P. Andersen, 2007 .

Competing risks

John P. Klein, J. Klein, J. Klein, 2010 .

Analyzing survival curves at a fixed point in time

John P Klein, Brent Logan, Per Kragh Andersen, 2007, Statistics in medicine.

A partially parametric estimator of survival in the presence of randomly censored data.

J. Klein, M. Moeschberger, S. C. Lee, 1990, Biometrics.